The present study also revealed that the anti-cancer protective effects induced by the immunization with non-replicable MC38 CRC cells with rGRA6Nt adjuvant is associated with markedly increased density of CD8+ T cells that have infiltrated into the MC38 tumors. This evidence concerns the gene CD8A and cancer.